Polański Piotr
National Institute of Public Health – National Institute of Hygiene, Department of Epidemiology
Przegl Epidemiol. 2016;70(2):225-230.
The aim of this article is to assess the epidemiological situation of hepatitis A in Poland in 2014 with the regard to the recent years.
The assessment was conducted based on the results of the analysis of data from the bulletins “Infectious diseases and poisonings in Poland in 2014” and “Vaccinations in Poland in 2014”, as well as information from the individual cases questionnaires and reports of epidemiological investigations in outbreaks of hepatitis A, submitted by the sanitary-epidemiological stations to the Department of Epidemiology in NIPH-NIH.
In 2014 in Poland there were 76 cases of hepatitis A registered. Incidence per 100 000 inhabitants was 0.20, and in different voivodeships varied from 0.07 (in Dolnosląskie voivodeship) to 0.30 (in Małopolskie voivodeship). The incidence among male and female did not differ (and was 0.20/ 100 000).
In 2014 despite the increase in the number of cases (comparing it to the previous year) no significant change in epidemiological situation of hepatitis A was observed. Poland is still regarded as a country of low endemicity of hepatitis A. In routine surveillance system there is no information concerning the professional affiliation of persons being vaccinated, whereas the vaccinations themselves are recommended in the Polish vaccination schedule. Particular attention should be directed towards the vaccinations of persons who take part in berries primal production, product of which Poland is a major exporter of in the EU. In the light of increasing number of international hepatitis A outbreaks (which could be characterized by the prolonged duration, as well as the high possibility of secondary cases appearing- especially in countries of low endemicity) the maintenance of high level routine surveillance in Poland gains importance. The latter could also contribute to the efficiency of epidemiological investigations in multistate outbreaks.
本文旨在评估2014年波兰甲型肝炎的流行病学状况,并与近年来的情况进行比较。
评估是基于对“2014年波兰传染病与中毒情况”及“2014年波兰疫苗接种情况”公告中的数据分析结果,以及卫生流行病学站提交给国家公共卫生研究所 - 国家卫生研究院流行病学部的甲型肝炎疫情中个别病例调查问卷和流行病学调查报告中的信息进行的。
2014年波兰登记了76例甲型肝炎病例。每10万居民的发病率为0.20,在不同省份从0.07(下西里西亚省)到0.30(小波兰省)不等。男性和女性的发病率没有差异(均为0.20/10万)。
2014年,尽管病例数有所增加(与上一年相比),但甲型肝炎的流行病学状况未观察到显著变化。波兰仍被视为甲型肝炎低流行国家。在常规监测系统中,没有关于接种疫苗者职业归属的信息,而波兰疫苗接种计划中推荐了疫苗接种本身。应特别关注参与浆果初级生产的人员的疫苗接种,波兰是欧盟此类产品的主要出口国。鉴于国际甲型肝炎疫情数量不断增加(其特点可能是持续时间长,以及出现二代病例的可能性高 - 特别是在低流行国家),在波兰维持高水平的常规监测变得至关重要。这也有助于提高多州疫情中流行病学调查的效率。